- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, June 18, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A story published by The Columbus Dispatch cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, titled “Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs,” indicated that as the first quarter of 2021 ended, patients choosing to keep using secukinumab may have been offered an inducement to switch to another biologic, ixekizumab.
A press release issued by Cano Health referenced a study published in the June 2021 issue of AJMC®, titled “Managed Care COVID-19 Outcomes in a Population Health Program.” The study found that COVID-19–specific mortality for Cano Health members was 60% lower compared with an age- and gender-matched mirror group of Florida residents.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
